Stock Earnings

Question 1

What are Dermapharm Holding SE's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Dermapharm Holding SE has a total asset of $2,080, Net profit of $113

Question 2

What are the key financial ratios for DMPHF?

Accepted Answer

Dermapharm Holding SE's Current ratio is 1.41, has a Net margin is 9.57, sales per share of $21.91.

Question 3

How is Dermapharm Holding SE's revenue broken down by segment or geography?

Accepted Answer

Dermapharm Holding SE largest revenue segment is Branded Medicine, at a revenue of 585,058,000 in the most earnings release.For geography, Germany is the primary market for Dermapharm Holding SE, at a revenue of 725,563,000.

Question 4

Is Dermapharm Holding SE profitable?

Accepted Answer

yes, according to the latest financial statements, Dermapharm Holding SE has a net profit of $113

Question 5

Does Dermapharm Holding SE have any liabilities?

Accepted Answer

yes, Dermapharm Holding SE has liability of 1,475

Question 6

How many outstanding shares for Dermapharm Holding SE?

Accepted Answer

Dermapharm Holding SE has a total outstanding shares of 53.84

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	1,176	1,180	1,135	1,024	942	793
Revenue Growth (YoY)	4%	4%	11%	9%	19%	13%
Cost of Revenue	403	413	416	363	322	330
Gross Profit	772	767	719	660	620	463
Selling, General & Admin	287	424	418	290	257	257
Research & Development	--	11	10	13	14	12
Operating Expenses	554	539	518	377	325	320
Other Non Operating Income (Expenses)	0	-4	-3	-1	0	-1
Pretax Income	163	172	105	216	292	125
Income Tax Expense	57	60	45	83	84	39
Net Income	107	113	62	134	209	85
Net Income Growth	28.99%	82%	-54%	-36%	146%	10%
Shares Outstanding (Diluted)	53.57	53.84	53.84	53.84	53.84	53.84
Shares Change (YoY)	0%	0%	0%	0%	0%	0%
EPS (Diluted)	1.99	2.11	1.15	2.49	3.89	1.59
EPS Growth	28.99%	82%	-54%	-36%	144%	11%
Free Cash Flow	175	163	177	249	189	91
Free Cash Flow Per Share	3.26	3.02	3.28	4.62	3.51	1.69
Gross Margin	65.64%	65%	63.34%	64.45%	65.81%	58.38%
Operating Margin	18.53%	19.23%	17.62%	27.63%	31.31%	17.9%
Profit Margin	9.09%	9.57%	5.46%	13.08%	22.18%	10.71%
Free Cash Flow Margin	14.88%	13.81%	15.59%	24.31%	20.06%	11.47%
EBITDA	302	313	301	377	340	185
EBITDA Margin	25.68%	26.52%	26.51%	36.81%	36.09%	23.32%
D&A For EBITDA	84	86	101	94	45	43
EBIT	218	227	200	283	295	142
EBIT Margin	18.53%	19.23%	17.62%	27.63%	31.31%	17.9%
Effective Tax Rate	34.96%	34.88%	42.85%	38.42%	28.76%	31.2%

Dermapharm Holding SE (DMPHF) Price

DMPHF Stock Price Chart

DMPHF Income

Follow-Up Questions